Half Year 2021 Poxel SA Earnings Call(English) Transcript
Hello, everyone. Welcome to Poxel's Half Year 2021 Results Presentation. (Operator Instructions) Thomas, I give you the floor.
Thank you very much, and thank you for joining us today. I'm Thomas Kuhn, I'm the CEO of the company. After my introductory comments, I will hand the call to Anne Renevot, our CFO, to review the first half 2021 financial results. And then David Moller, Chief Scientific Officer, will provide an update on our clinical pipeline.
Before we begin, this is our forward-looking statements. Just to remind that forward-looking statements are subject to inherent risks and uncertainties beyond the company's control that could cause the company's actual results or performance to be materially different from the expected results or performance expressed or implied by such forward-looking statements. Further information can be found in our most recent regulatory filings.
So as some of you know, Poxel's mission and vision remain to discover, develop and commercialize innovative
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |